Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Consolidated Net Profit

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹9.49 Cr₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr

What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?

The latest Consolidated Net Profit ratio of MEDICAMEN BIOTECH is ₹9.49 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹9.49 Cr
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr

How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹9.49 Cr
-35.54
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr -

Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹320.6 Cr -1.2% -3.9% -38.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.2%

-3.9%

-38.5%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses